-
Introduction of four energy-saving measures in the walk-in constant temperature and humidity laboratory
Time of Update: 2022-10-19
The hoarding panel of the British LK coordinate measuring instrument room is made of 0426 polystyrene thin sandwich panel: the board thickness is 75mm, and the interior is filled with foam plastic filler masterbatch with a relative density of 12kg/m3 as thermal insulation wall, which belongs to high-efficiency thermal insulation materials, thermal insulation is easy to use, reducing the outflow of cooling capacity, and considering the provisions of environmental protection and energy saving.
-
The Winter Olympics will again raise the "ice and snow equipment fever", and polymer materials will help
Time of Update: 2022-09-17
Composite materials reduce weight and strengthen snowboardsComposite materials reduce weight and strengthen snowboardsIf you want to "float" on snow, lightweight, high-strength and low-damping skis are indispensable!
Composite materials reduce weight and strengthen snowboardsComposite materials reduce weight and strengthen snowboardsIf you want to "float" on snow, lightweight, high-strength and low-damping skis are indispensable!
-
The salaries of executives of eleven listed instrument companies in 2021 are "exposed
Time of Update: 2022-05-25
1572 million yuan from the company, director and general manager Zhang Yan received a total pre-tax remuneration of 1.
The total pre-tax remuneration received by the general manager and secretary of the board of directors Chen Liling from the company is 513,900 yuan .
-
This year 33 biopharmaceutical companies have landed on the Science and Technology Innovation Board, and the market value of 13 has exceeded 10 billion
Time of Update: 2021-12-28
In addition, Dizhe Pharmaceutical, an innovation-driven biomedical company that recently landed on the Science and Technology Innovation Board, has a market value of more than 10 billion yuan .
-
What is the reason behind the high failure rate of 19 pharmaceutical companies that failed to go public
Time of Update: 2021-11-04
Since the beginning of this year, a total of 10 biopharmaceuticals, pharmaceutical R&D and experimental companies have failed IPOs on the Sci-tech Innovation Board, which is higher than the total of the previous two years (4 in 2019 and 5 in 2020), of which 8 have voluntarily withdrawn .
-
Pien Tze Huang issued an announcement, Chairman Liu Jianshun resigned
Time of Update: 2021-04-18
The company's core product, Pien Tze Huang, is a nationally certified first-level protected traditional Chinese medicine, and is also a national top-secret formula.
The company's core product, Pien Tze Huang, is a nationally certified first-level protected traditional Chinese medicine, and is also a national top-secret formula.
-
Stone Pharmaceutical Group: Revenue of 12.59 billion yuan in the first half of 2020, up 12.6% YoY
Time of Update: 2020-09-27
the first half of 2020, the pharmaceutical business recorded sales revenue of RMB10,231 million, an increase of 16.7% over the same period last year.
research and development expenses amounted to RMB1,452 million (included in the income statement), an increase of 54.2% YoY, accounting for about 14.2% of the revenue of the pharmaceutical business.
-
Safety and protection of sand blasting
Time of Update: 2020-03-04
1 Sand blasting machines, pipes and joints must be firmly installed and reliably connected to ensure no leakage During the work, it should also be checked frequently to see if there is any air leakage
-
Corning announces financial results for the fourth quarter and full year of 2019
Time of Update: 2020-02-03
Corning incorporated (NYSE: GLW) recently announced its fourth quarter and full year financial results for 2019 "Thanks to the strong performance of the three business units, the company's sales in 20
-
Analysis of drug development and market status of rare multiple sclerosis in 2019
Time of Update: 2019-12-24
By Zhang Yuefei Make up ginger With the introduction of favorable policies in China, the diagnosis, treatment and drug research and development of rare diseases in China are gradually on the right tra
